Unknown

Dataset Information

Effect of the aggregated protein dye YAT2150 on <i>Leishmania</i> parasite viability.


ABSTRACT: The problems associated with the drugs currently used to treat leishmaniasis, including resistance, toxicity, and the high cost of some formulations, call for the urgent identification of new therapeutic agents with novel modes of action. The aggregated protein dye YAT2150 has been found to be a potent antileishmanial compound, with a half-maximal inhibitory concentration (IC50) of approximately 0.5 µM against promastigote and amastigote stages of Leishmania infantum. The encapsulation in liposomes of YAT2150 significantly improved its in vitro IC50 to 0.37 and 0.19 µM in promastigotes and amastigotes, respectively, and increased the half-maximal cytotoxic concentration in human umbilical vein endothelial cells to >50 µM. YAT2150 became strongly fluoresc

SUBMITTER: Roman-Alamo L 

PROVIDER: S-EPMC10916400 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature